HomeMRKR • NASDAQ
add
Marker Therapeutics Inc
Previous close
$3.26
Day range
$3.15 - $3.53
Year range
$2.40 - $6.16
Market cap
31.41M USD
Avg Volume
39.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 1.17M | 53.31% |
Operating expense | 1.14M | -54.66% |
Net income | -2.19M | -187.16% |
Net profit margin | -187.53 | -156.85% |
Earnings per share | -0.25 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.80M | -56.96% |
Total assets | 11.68M | -46.82% |
Total liabilities | 1.97M | -32.48% |
Total equity | 9.70M | — |
Shares outstanding | 8.92M | — |
Price to book | 2.99 | — |
Return on assets | -44.79% | — |
Return on capital | -53.70% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -2.19M | -187.16% |
Cash from operations | -3.57M | 49.44% |
Cash from investing | — | — |
Cash from financing | 44.61K | 5,960.60% |
Net change in cash | -3.52M | -130.06% |
Free cash flow | -2.82M | 16.03% |
About
Founded
1992
Headquarters
Website
Employees
8